Tepezza
Chemical Name | teprotumumab-trbw |
Dosage Form | Injection (intravenous; 500 mg/vial) |
Drug Class | Monoclonal antibodies |
System | Endocrine |
Company | Horizon Therapeutics |
Approval Year | 2020 |
Indication
- For the treatment of Thyroid Eye Disease
Chemical Name | teprotumumab-trbw |
Dosage Form | Injection (intravenous; 500 mg/vial) |
Drug Class | Monoclonal antibodies |
System | Endocrine |
Company | Horizon Therapeutics |
Approval Year | 2020 |